Casdin 资本 对 BNTX 的持仓历史
BIONTECH SE · 医疗保健
Casdin 资本 在 Q3 2026 的 13F 申报中披露持有 BNTX(BIONTECH SE)85,000 股,市值约 US$8.4M,约占其申报组合的 0.37%,在其申报持仓中市值排名第 34 位。 Casdin 资本 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Casdin 资本 对 BNTX 的持仓演变
Casdin 资本 于 Q3 2026 首次披露 BNTX 持仓:85,000 股(约 US$8.4M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 85.00K | $8.36M | 新进 |
关于 BNTX 与 13F 数据
BNTX(BIONTECH SE)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 BNTX,申报仓位最大的包括:Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BNTX 的基金
- Davern Capital Partners, LP 682.15K 股 · $67.06M · Q3 2026
- GSK plc 668.53K 股 · $65.72M · Q3 2026
- Logos Global Management LP 650.00K 股 · $63.90M · Q3 2026
- Long Focus Capital Management, LLC 632.00K 股 · $62.13M · Q3 2026
- SAMLYN CAPITAL, LLC 561.70K 股 · $55.21M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K 股 · $46.20M · Q3 2026
更多关于 Casdin 资本
常见问题
How long has Casdin 资本 held BNTX?
Casdin 资本 has disclosed BNTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Casdin 资本's current position in BNTX?
As of Q3 2026, Casdin 资本 holds 85.00K shares of BNTX (BIONTECH SE), valued at $8.36M, representing 0.37% of its reported portfolio and ranking #34.
Has Casdin 资本 been buying or selling BNTX?
In the latest 13F filing (Q3 2026), Casdin 资本 newly opened its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.